Genscript Biotech Corp
HKEX:1548
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.23
23.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 32.97 HKD. Compared to the current market price of 11 HKD, Genscript Biotech Corp is Undervalued by 67%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Genscript Biotech Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Genscript Biotech Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Genscript Biotech Corp
Balance Sheet Decomposition
Genscript Biotech Corp
Current Assets | 2.4B |
Cash & Short-Term Investments | 1.9B |
Receivables | 299.5m |
Other Current Assets | 125.5m |
Non-Current Assets | 1B |
Long-Term Investments | 90.8m |
PP&E | 750.9m |
Intangibles | 20m |
Other Non-Current Assets | 172.4m |
Current Liabilities | 494.8m |
Accounts Payable | 40m |
Accrued Liabilities | 165.9m |
Short-Term Debt | 56.9m |
Other Current Liabilities | 232m |
Non-Current Liabilities | 1.5B |
Long-Term Debt | 351.1m |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
Genscript Biotech Corp
Revenue
|
1B
USD
|
Cost of Revenue
|
-468.1m
USD
|
Gross Profit
|
541.5m
USD
|
Operating Expenses
|
-936.5m
USD
|
Operating Income
|
-395m
USD
|
Other Expenses
|
218m
USD
|
Net Income
|
-177m
USD
|
Free Cash Flow Analysis
Genscript Biotech Corp
USD | |
Free Cash Flow | USD |
Profitability Score
Profitability Due Diligence
Genscript Biotech Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Genscript Biotech Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Genscript Biotech Corp
According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.7 HKD with a low forecast of 16.16 HKD and a high forecast of 30.59 HKD.
Dividends
Current shareholder yield for Genscript Biotech Corp is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.
Contact
IPO
Employees
Officers
The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 32.97 HKD.
Compared to the current market price of 11 HKD, Genscript Biotech Corp is Undervalued by 67%.